rdf:type |
|
lifeskim:mentions |
umls-concept:C0006610,
umls-concept:C0022917,
umls-concept:C0024305,
umls-concept:C0202113,
umls-concept:C0205265,
umls-concept:C0205473,
umls-concept:C0229671,
umls-concept:C0441889,
umls-concept:C0851148,
umls-concept:C0918012,
umls-concept:C1423594,
umls-concept:C1527178,
umls-concept:C1538046,
umls-concept:C1555582,
umls-concept:C1705938,
umls-concept:C2346918
|
pubmed:issue |
11
|
pubmed:dateCreated |
2001-1-4
|
pubmed:abstractText |
Serum CA125 (sCA125) was recently reported to be of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma (NHL). This report aims to investigate the prognostic value of a new serologic index combining sCA125 and LDH serum levels.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0923-7534
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1485-91
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11142490-Adult,
pubmed-meshheading:11142490-Aged,
pubmed-meshheading:11142490-CA-125 Antigen,
pubmed-meshheading:11142490-Disease-Free Survival,
pubmed-meshheading:11142490-Female,
pubmed-meshheading:11142490-Follow-Up Studies,
pubmed-meshheading:11142490-Humans,
pubmed-meshheading:11142490-L-Lactate Dehydrogenase,
pubmed-meshheading:11142490-Life Tables,
pubmed-meshheading:11142490-Lymphoma, Non-Hodgkin,
pubmed-meshheading:11142490-Male,
pubmed-meshheading:11142490-Middle Aged,
pubmed-meshheading:11142490-Neoplasm Proteins,
pubmed-meshheading:11142490-Neoplasm Staging,
pubmed-meshheading:11142490-Prognosis,
pubmed-meshheading:11142490-Remission Induction,
pubmed-meshheading:11142490-Severity of Illness Index,
pubmed-meshheading:11142490-Survival Analysis,
pubmed-meshheading:11142490-Treatment Outcome,
pubmed-meshheading:11142490-Tumor Markers, Biological,
pubmed-meshheading:11142490-beta 2-Microglobulin
|
pubmed:year |
2000
|
pubmed:articleTitle |
A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.
|
pubmed:affiliation |
Department of Hematology/Oncology, H pital Bretonneau, Tours, France. l.Benboubker@bretonneau.chu-tours.fr
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|